Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?

Fertil Steril. 2014 Jun;101(6):1624-8. doi: 10.1016/j.fertnstert.2014.02.036. Epub 2014 Mar 26.

Abstract

Objective: To examine whether patients with poor ovarian response (POR) during conventional IVF/intracytoplasmic sperm injection (ICSI) treatment cycle may benefit from a modified natural cycle (MNC)-IVF.

Design: Cohort historic study.

Setting: Tertiary, university-affiliated medical center.

Patient(s): One hundred eleven patients with POR, defined according to the Bologna criteria, who underwent a subsequent MNC-IVF within 3 months of the previous failed conventional IVF/ICSI cycle. The elimination of bias in this selection, for the purposes of this study, was achieved by including only a subgroup of "genuine" poor responder patients, those who yielded up to three oocytes after controlled ovarian hyperstimulation (COH) with a minimal gonadotropin daily dose of 300 IU.

Intervention(s): Modified natural cycle IVF protocol with GnRH antagonist (GnRH-a) supplementation. Gonadotropin-releasing hormone antagonist treatment was started when a follicle of 13 mm was present. Two to three ampules of hMG were coadministered daily during the GnRH-a treatment.

Main outcome measure(s): Live birth rate, pregnancy rate (PR), number of oocytes retrieved, and number of embryos transferred.

Result(s): Live birth rate in "genuine" poor ovarian responders was <1%. Furthermore, in the subgroup of patients with POR who underwent a previous conventional IVF/ICSI cycle with a yield of only one oocyte, no pregnancies were achieved during the MNC-IVF cycle.

Conclusion(s): Modified natural cycle-IVF is of no benefit for genuine poor ovarian responders and the option of egg donation should be seriously considered for this population.

Keywords: IVF; Modified natural cycle; poor response.

MeSH terms

  • Adult
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Fertility Agents, Female / administration & dosage*
  • Fertilization in Vitro / methods*
  • Gonadotropin-Releasing Hormone / administration & dosage
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors
  • Gonadotropin-Releasing Hormone / metabolism
  • Hormone Antagonists / administration & dosage
  • Humans
  • Infertility, Female / diagnosis
  • Infertility, Female / drug therapy*
  • Infertility, Female / physiopathology
  • Live Birth
  • Menotropins / administration & dosage
  • Ovary / drug effects*
  • Ovary / physiopathology
  • Ovulation / drug effects*
  • Ovulation Induction / methods*
  • Pregnancy
  • Pregnancy Rate
  • Retrospective Studies
  • Sperm Injections, Intracytoplasmic
  • Treatment Outcome

Substances

  • Fertility Agents, Female
  • Hormone Antagonists
  • Gonadotropin-Releasing Hormone
  • Menotropins
  • cetrorelix